FdaApplication

NDA 021961

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSYNTHON PHARMACEUTICALS LTD
application_typeNDA
approval_date2007-10-09

Products (4)

ProductActive ingredientStrengthDosage form
SIMVASTATINSIMVASTATIN20MGTABLET, ORALLY DISINTEGRATING;ORAL
SIMVASTATINSIMVASTATIN10MGTABLET, ORALLY DISINTEGRATING;ORAL
SIMVASTATINSIMVASTATIN40MGTABLET, ORALLY DISINTEGRATING;ORAL
SIMVASTATINSIMVASTATIN80MGTABLET, ORALLY DISINTEGRATING;ORAL

4 products